Metformin’s Potential Role in PCO - Takeaways - MDSpire

Metformin’s Potential Role in PCO

Common diabetes therapy reaches intraocular lens tissue and may help limit posterior capsule opacification, says newly published data

  • By

  • Conexiant News Staff

  • March 5, 2026

  • 3 min

Share

  • 1

    Metformin may reduce the incidence of posterior capsule opacification (PCO) after cataract surgery, a common long-term complication.

  • 2

    A study found that metformin accumulates in the human lens capsule, correlating with serum concentrations in patients with type 2 diabetes.

  • 3

    In vitro assays showed that metformin significantly attenuates lens epithelial cell (LEC) proliferation, a key factor in PCO development.

  • 4

    The findings suggest that metformin use may modify PCO risk, potentially explaining conflicting epidemiological data regarding diabetes.

  • 5

    The authors advocate for larger studies to further explore metformin's role as a pharmacological adjunct in PCO prevention.

Original Source(s)

Metformin’s Potential Role in PCO

  • by Conexiant News Staff

  • March 5, 2026

Related Content

Advocacy Pays Off for ASCs

At the Outpatient Ophthalmic Surgery Society’s “OOSS Perspective 2026” symposium in Washington, DC, the organization's Washington counsel, Michael Romansky, JD, delivered an update on reimbursement, regulatory developments, and advocacy priorities affecting ophthalmic ambulatory surgery centers (ASCs).

Impact of extended reality (XR) simulation on ophthalmology training outcomes: an updated systematic review and meta-analysis

ASC Growing Pains

Daniel Eisenstadt of Terramed Real Estate Solutions discusses factors that contribute to limited surgical capacity and what can be done about them.

  • May 1, 2026

  • 5 min